1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives.

Source:http://linkedlifedata.com/resource/pubmed/id/16335918

J. Med. Chem. 2005 Dec 15 48 25 7932-45

Download in:

View as

General Info

PMID
16335918